Biotech

Solid Biosciences (NASDAQ:SLDB) today announced the pricing of its initial public offering of 7,812,500 shares of its common stock at a price to the public of $16.00 per share, for total gross proceeds of approximately $125,000,000. As quoted in the press release: In addition, the underwriters have a 30-day option to purchase up to 1,171,875 …

Solid Biosciences (NASDAQ:SLDB) today announced the pricing of its initial public offering of 7,812,500 shares of its common stock at a price to the public of $16.00 per share, for total gross proceeds of approximately $125,000,000.
As quoted in the press release:

In addition, the underwriters have a 30-day option to purchase up to 1,171,875 additional shares of common stock at the initial public offering price less underwriting discounts and commissions. The shares are expected to begin trading on the Nasdaq Global Select Market on January 26, 2018 under the symbol “SLDB.” The offering is expected to close on January 30, 2018, subject to customary closing conditions.

Click here to read the full press release.

Featured

MARKETS

Markets
TSX20437.04+150.84
TSXV700.05-0.61
DOW32217.80+289.18
S&P 5003994.27+52.79
NASD11490.91+226.46
ASX7128.80-20.10

COMMODITIES

Commodities
Gold1854.59-12.71
Silver22.04-0.09
Copper4.28-0.02
Palladium2013.65+16.65
Platinum950.15-5.84
Oil110.74+0.97
Heating Oil3.75+0.10
Natural Gas8.88+0.09

DOWNLOAD FREE REPORTS

×